Michio Sakai

842 total citations
32 papers, 498 citations indexed

About

Michio Sakai is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Michio Sakai has authored 32 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 8 papers in Genetics and 5 papers in Surgery. Recurrent topics in Michio Sakai's work include Platelet Disorders and Treatments (14 papers), Hemophilia Treatment and Research (14 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Michio Sakai is often cited by papers focused on Platelet Disorders and Treatments (14 papers), Hemophilia Treatment and Research (14 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Michio Sakai collaborates with scholars based in Japan, United States and Greece. Michio Sakai's co-authors include Akira Shirahata, Tadashi Matsushita, Hidehiko Saito, Midori Shima, Shinji Kunishima, Satoshi Higasa, Masashi Taki, Masashi Sanada, Yoshiyuki Takahashi and Satoru Miyano and has published in prestigious journals such as New England Journal of Medicine, The American Journal of Human Genetics and Journal of Medical Virology.

In The Last Decade

Michio Sakai

29 papers receiving 477 citations

Peers

Countries citing papers authored by Michio Sakai

Since Specialization

Citations

This map shows the geographic impact of Michio Sakai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michio Sakai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michio Sakai more than expected).

Fields of papers citing papers by Michio Sakai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michio Sakai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michio Sakai. The network helps show where Michio Sakai may publish in the future.

Co-authorship network of co-authors of Michio Sakai

This figure shows the co-authorship network connecting the top 25 collaborators of Michio Sakai. A scholar is included among the top collaborators of Michio Sakai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michio Sakai. Michio Sakai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Linguistic validation of Barriers to Being Active Quiz (BBAQ-21) in Japanese patients with hemophilia 2023 ·Japanese Journal of Thrombosis and Hemostasis ·Hideyuki Takedani, Akira Shirahata, Michio Sakai, (unknown), (unknown), (unknown), Ayako Shoji, (unknown)	0
2	Plasma‐derived factor VIIa and factor X mixture agent (MC710) prophylaxis in haemophilia B patients with inhibitors 2022 ·Haemophilia ·Michio Sakai, Kagehiro Amano, Motoaki Chin, Hideyuki Takedani, Hiroyuki Ishida, Kazuo Sakashita, Masashi Taki, Masahiro Migita, Hiroyoshi Watanabe, Masataka Ishimura, Keiji Nogami, (unknown), Akira Shirahata	4
3	Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B 2019 ·Haemophilia ·Katsuyuki Fukutake, Masashi Taki, Tadashi Matsushita, Michio Sakai, (unknown), Hiromi Yamaguchi, (unknown)	3
4	Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations 2017 ·International Journal of Hematology ·Keiji Nogami, Midori Shima, Katsuyuki Fukutake, Teruhisa Fujii, Masashi Taki, Tadashi Matsushita, Satoshi Higasa, Tetsuji Sato, Michio Sakai, Morio Arai, (unknown), Werner Engl, Brigitt E. Abbuehl, Barbara A. Konkle	7
5	The International Immune Tolerance Induction Study and its follow-up study on Japanese hemophilia A patients with inhibitors 2015 ·International Journal of Hematology ·Akira Yoshioka, (unknown), (unknown), Ikuya Usami, Masao Kobayashi, Ryōji Kobayashi, Manabu Sotomatsu, Akira Shirahata, Takashi Suzuki, Masashi Taki, Yasushi Ishida, Tadashi Matsushita, Midori Shima, Keiji Nogami, Michio Sakai, Hisato Kigasawa, Katsuyuki Fukutake	3
6	Long-term follow-up of children with refractory immune thrombocytopenia treated with rituximab 2014 ·International Journal of Hematology ·Kousaku Matsubara, Yoshiyuki Takahashi, Akira Hayakawa, Fumiko Tanaka, Hisaya Nakadate, Michio Sakai, Naoko Maeda, Toshiaki Oka, Eiichi Ishii, Fumio Bessho, Tsuyoshi Morimoto, Hiroaki Goto, Yoshiko Hashii, Naoki Hatakeyama, Akira Shirahata, Masue Imaizumi	13
7	The prevalence of neutralizing antibodies against adeno‐associated virus capsids is reduced in young Japanese individuals 2013 ·Journal of Medical Virology ·Jun Mimuro, Hiroaki Mizukami, Midori Shima, Tadashi Matsushita, Masashi Taki, (unknown), Satoshi Higasa, Michio Sakai, Tsukasa Ohmori, Seiji Madoiwa, Keiya Ozawa, Yoichi Sakata	62
8	ACTN1 Mutations Cause Congenital Macrothrombocytopenia 2013 ·The American Journal of Human Genetics ·Shinji Kunishima, Yusuke Okuno, Kenichi Yoshida, Yuichi Shiraishi, Masashi Sanada, Hideki Muramatsu, Kenichi Chiba, Hiroko Tanaka, Kôji Miyazaki, Michio Sakai, Masatoshi Ohtake, Ryōji Kobayashi, Akihiro Iguchi, (unknown), Makoto Otsu, Yoshiyuki Takahashi, Satoru Miyano, Hidehiko Saito, Seiji Kojima, Seishi Ogawa	130
9	Bernard-Soulier Syndrome due to Compound Heterozygosity for a Novel Glycoprotein Ibβ Mutation 2013 ·Acta Haematologica ·Tetsuji Sato, Shinji Kunishima, (unknown), (unknown), Michio Sakai, Koichi Kusuhara	0
10	Thrombosis from a Prothrombin Mutation Conveying Antithrombin Resistance 2012 ·New England Journal of Medicine ·(unknown), Atsuo Suzuki, Junko Fujita, (unknown), (unknown), (unknown), Akira Takagi, Takashi Murate, Shinji Kunishima, Michio Sakai, Kohji Okamoto, Tadashi Matsushita, Tomoki Naoe, Hidehiko Saito, Tetsuhito Kojima	74
11	Results of clot waveform analysis and thrombin generation test for a plasma‐derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors—phase I trial: 2nd report 2012 ·Haemophilia ·Akira Shirahata, Katsuyuki Fukutake, (unknown), Junki Takamatsu, Midori Shima, Hideji Hanabusa, Hideyuki Takedani, (unknown), Tadashi Matsushita, Akio Tawa, Satoshi Higasa, Noboru Takata, Michio Sakai, Kiyoshi Kawakami, Yuichi Ohashi, Hidehiko Saito	19
12	Clinical pharmacological study of a plasma‐derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors – Phase I trial 2011 ·Haemophilia ·Akira Shirahata, Katsuyuki Fukutake, (unknown), Junki Takamatsu, Midori Shima, Hideji Hanabusa, Hideyuki Takedani, (unknown), Tadashi Matsushita, Akio Tawa, Satoshi Higasa, Noboru Takata, Michio Sakai, Kiyoshi Kawakami, Yuichi Ohashi, Hidehiko Saito	14
13	Effect of transfusion on the venous blood lactate level in very low‐birthweight infants 2009 ·Pediatrics International ·(unknown), (unknown), (unknown), Tetsuji Sato, Ryosuke Miyaji, Michio Sakai, Akira Shirahata	10
14	A 3-year consecutive survey on current status of acquired inhibitors against coagulation factors in Japan 2008 ·Japanese Journal of Thrombosis and Hemostasis ·Ichiro Tanaka, Kagehiro Amano, Masashi Taki, Toshiaki Oka, Michio Sakai, Akira Shirahata, Noboru Takata, Junki Takamatsu, (unknown), Hideji Hanabusa, Satoshi Higasa, Katsuyuki Fukutake, Teruhisa Fujii, Tadashi Matsushita, (unknown), Akira Yoshioka, Midori Shima	15
15	Intramural Hematoma of the Cecum as the Lead Point of Intussusception in an Elderly Patient with Hemophilia A: Report of a Case 2006 ·Surgery Today ·Yoshifumi Nakayama, (unknown), Michio Sakai, Terumasa Hisano, Naoki Nagata, Akira Shirahata, Hideaki Itoh	15
16	HLA-B Polymorphism in Japanese HIV-1–Infected Long-Term Surviving Hemophiliacs 2005 ·Viral Immunology ·(unknown), Hiroshi Terunuma, Megumi Takahashi, Hideji Hanabusa, Takuma Miura, Shu‐ichi Ikeda, Michio Sakai, Teruhisa Fujii, Yoshihiro Takahashi, Shinichi Oka, Juzo Matsuda, Masaaki Ishikawa, Masashi Taki, (unknown), J Mimaya, Masahiko Ito, Akinori Kimura, Michio Yasunami	12
17	Successful steroid pulse treatment in childhood acquired haemophilia with nephrotic syndrome 2005 ·Haemophilia ·Michio Sakai, Midori Shima, Akira Shirahata	5
18	Decreased platelet aggregation of platelet concentrate during storage recovers in the body after transfusion 2004 ·Transfusion ·Ryosuke Miyaji, Michio Sakai, (unknown), (unknown), H Sakamoto, Akira Shirahata	32
19	Low Tissue Plasminogen Activator Relative to Plasminogen Activator Inhibitor-1 as a Marker of Cardiac Complication in Children With Kawasaki Disease 2001 ·Clinical and Applied Thrombosis/Hemostasis ·Michio Sakai, Kei Asayama, (unknown), (unknown), Akira Shirahata	12
20	Genetic Analysis of Protein C Deficiency in Nineteen Japanese Families 1998 ·Thrombosis Research ·Toshiyuki Miyata, Toshiyuki Sakata, (unknown), Takashi Okamura, Akira Katsumi, (unknown), Takashi Abe, Akira Shirahata, Michio Sakai, Hisao Kato	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact